Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 8/2014

01.08.2014 | Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section)

T1 Mapping in Heart Failure

verfasst von: Leah M. Iles, Glenn S. Slavin, Andrew J. Taylor

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

The pathophysiology of heart failure is characterized by abnormalities not only of the cardiomyocytes, but also by expansion of the extracellular space. Evolving recognition of these changes, and their important functional consequences, has prompted a search for accurate characterization of the myocardial interstitium. Previously, this has only been possible using histologic analysis; however, T1 mapping with cardiac magnetic resonance imaging has recently provided a noninvasive method to measure expansion of the myocardial interstitium. Literature over the past 6 years suggests T1 mapping could potentially provide crucial information for diagnosis, prognostication and for optimizing therapeutic targeting. However, the ideal methodology for both image acquisition and analysis remains an unresolved issue. Consequently, variations in methodology have complicated interpretation of the data, and limit comparisons between studies. This review provides a summary of important initial validation papers, and subsequent diagnostic, mechanistic and longitudinal studies of T1 mapping in heart failure. In addition, variations in methodology are discussed; highlighting current challenges facing scientists and clinicians interested in this evolving field.
Literatur
1.
Zurück zum Zitat Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update. Circulation. 2011;123:e18–209.PubMedCrossRef Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update. Circulation. 2011;123:e18–209.PubMedCrossRef
2.
Zurück zum Zitat Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.PubMedCentralPubMedCrossRef Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Cleutjens JP, Verluyten MJ, Smiths JF, et al. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol. 1995;147:325–38.PubMedCentralPubMed Cleutjens JP, Verluyten MJ, Smiths JF, et al. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol. 1995;147:325–38.PubMedCentralPubMed
4.
Zurück zum Zitat Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151–63.PubMedCrossRef Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151–63.PubMedCrossRef
5.••
Zurück zum Zitat Mewton N, Liu CY, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57:891–903. An excellent review of CMR evaluation of myocardial fibrosis. PubMedCrossRef Mewton N, Liu CY, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57:891–903. An excellent review of CMR evaluation of myocardial fibrosis. PubMedCrossRef
6.
Zurück zum Zitat Kim RJ, Chen EL, Lima JA, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94:3318–26.PubMedCrossRef Kim RJ, Chen EL, Lima JA, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94:3318–26.PubMedCrossRef
7.
Zurück zum Zitat Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002.PubMedCrossRef Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002.PubMedCrossRef
8.
Zurück zum Zitat Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.PubMedCrossRef Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.PubMedCrossRef
9.
Zurück zum Zitat Schulz-Menger J, Gross M, Messroghli D, et al. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol. 2003;42:513–8.PubMedCrossRef Schulz-Menger J, Gross M, Messroghli D, et al. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol. 2003;42:513–8.PubMedCrossRef
10.
Zurück zum Zitat McCrohon JA, Moon JCC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.PubMedCrossRef McCrohon JA, Moon JCC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.PubMedCrossRef
11.
Zurück zum Zitat Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–85.PubMedCrossRef Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–85.PubMedCrossRef
12.
Zurück zum Zitat Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57:821–8.PubMedCrossRef Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57:821–8.PubMedCrossRef
13.
Zurück zum Zitat Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414–21.PubMedCentralPubMedCrossRef Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414–21.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000;102:1388–93.PubMedCrossRef Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000;102:1388–93.PubMedCrossRef
16.
Zurück zum Zitat Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002;105:2512–7.PubMedCrossRef Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002;105:2512–7.PubMedCrossRef
17.
Zurück zum Zitat Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail. 2002;8(6 Suppl):S319–25.PubMedCrossRef Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail. 2002;8(6 Suppl):S319–25.PubMedCrossRef
18.
Zurück zum Zitat Kitamura M, Shimizu M, Ino H, et al. Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens. Clin Cardiol. 2001;24:325–9.PubMedCrossRef Kitamura M, Shimizu M, Ino H, et al. Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens. Clin Cardiol. 2001;24:325–9.PubMedCrossRef
19.
Zurück zum Zitat Marijianowski MM, Teeling P, Mann J, et al. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. J Am Coll Cardiol. 1995;25:1263–72.PubMedCrossRef Marijianowski MM, Teeling P, Mann J, et al. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. J Am Coll Cardiol. 1995;25:1263–72.PubMedCrossRef
20.
Zurück zum Zitat Schaper J, Speiser B. The extracellular matrix in the failing human heart. Basic Res Cardiol. 1992;87 Suppl 1:303–9.PubMed Schaper J, Speiser B. The extracellular matrix in the failing human heart. Basic Res Cardiol. 1992;87 Suppl 1:303–9.PubMed
21.
Zurück zum Zitat Scholz TD, Fleagle SR, Burns TL, et al. Nuclear magnetic resonance relaxometry of the normal heart: relationship between collagen content and relaxation times of the four chambers. Magn Reson Imaging. 1989;7:643–8.PubMedCrossRef Scholz TD, Fleagle SR, Burns TL, et al. Nuclear magnetic resonance relaxometry of the normal heart: relationship between collagen content and relaxation times of the four chambers. Magn Reson Imaging. 1989;7:643–8.PubMedCrossRef
22.
Zurück zum Zitat Grover-McKay M, Scholz TD, Burns TL, et al. Myocardial collagen concentration and nuclear magnetic resonance relaxation times in the spontaneously hypertensive rat. Invest Radiol. 1991;26:227–32.PubMedCrossRef Grover-McKay M, Scholz TD, Burns TL, et al. Myocardial collagen concentration and nuclear magnetic resonance relaxation times in the spontaneously hypertensive rat. Invest Radiol. 1991;26:227–32.PubMedCrossRef
23.
Zurück zum Zitat Toni R, Boicelli CA, Baldassarri AM. Characterization of human pathological papillary muscles by 1H-NMR spectroscopic and histologic analysis. Int J Cardiol. 1986;11:231–4.PubMedCrossRef Toni R, Boicelli CA, Baldassarri AM. Characterization of human pathological papillary muscles by 1H-NMR spectroscopic and histologic analysis. Int J Cardiol. 1986;11:231–4.PubMedCrossRef
24.
Zurück zum Zitat Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186–93.PubMedCrossRef Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186–93.PubMedCrossRef
25.
Zurück zum Zitat Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574–80.PubMedCrossRef Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574–80.PubMedCrossRef
26.
Zurück zum Zitat Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.PubMedCrossRef Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.PubMedCrossRef
27.••
Zurück zum Zitat Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475–84. An elegant study providing both diagnostic utility of T 1 mapping in addition to echocardiographic comparisons with CMR findings. Presents data from all currently used T1 mapping methodologies for open comparison. PubMedCrossRef Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475–84. An elegant study providing both diagnostic utility of T 1 mapping in addition to echocardiographic comparisons with CMR findings. Presents data from all currently used T1 mapping methodologies for open comparison. PubMedCrossRef
28.
Zurück zum Zitat Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6:295–301.PubMedCrossRef Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6:295–301.PubMedCrossRef
29.•
Zurück zum Zitat Sibley CT, Noureldin RA, Gai N, et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology. 2012;265:724–32. The largest histologic validation study for T 1 mapping. PubMedCentralPubMedCrossRef Sibley CT, Noureldin RA, Gai N, et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology. 2012;265:724–32. The largest histologic validation study for T 1 mapping. PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Gai N, Turkbey EB, Nazarian S, et al. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med. 2011;65:1407–15.PubMedCentralPubMedCrossRef Gai N, Turkbey EB, Nazarian S, et al. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med. 2011;65:1407–15.PubMedCentralPubMedCrossRef
31.••
Zurück zum Zitat Mascherbauer J, Marzluf BA, Tufaro C, et al. Cardiac magnetic resonance postcontrast t1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. 2013;6:1056–65. A comprehensive evaluation of CMR, echocardiographic, histologic, invasive hemodynamic and longitudinal data in HFPEF. PubMedCrossRef Mascherbauer J, Marzluf BA, Tufaro C, et al. Cardiac magnetic resonance postcontrast t1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. 2013;6:1056–65. A comprehensive evaluation of CMR, echocardiographic, histologic, invasive hemodynamic and longitudinal data in HFPEF. PubMedCrossRef
32.
Zurück zum Zitat Miller CA, Naish JH, Bishop P, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373–83.PubMedCrossRef Miller CA, Naish JH, Bishop P, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373–83.PubMedCrossRef
33.
Zurück zum Zitat Iles LM, Taylor AJ. Letter by Iles and Taylor regarding article, “Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume”. Circ Cardiovasc Imaging. 2013;6:e25.PubMedCrossRef Iles LM, Taylor AJ. Letter by Iles and Taylor regarding article, “Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume”. Circ Cardiovasc Imaging. 2013;6:e25.PubMedCrossRef
34.
Zurück zum Zitat Miller CA, Naish JH, Bishop P, et al. Response to letter regarding article, “Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume”. Circ Cardiovasc Imaging. 2013;6:e26–7.PubMedCrossRef Miller CA, Naish JH, Bishop P, et al. Response to letter regarding article, “Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume”. Circ Cardiovasc Imaging. 2013;6:e26–7.PubMedCrossRef
35.
Zurück zum Zitat White SK, Sado DM, Fontana M, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only vs primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955–62.PubMedCrossRef White SK, Sado DM, Fontana M, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only vs primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955–62.PubMedCrossRef
36.
37.
Zurück zum Zitat Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012;33:1268–78.PubMedCentralPubMedCrossRef Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012;33:1268–78.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Liu CY, Liu YC, Wu C, et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;62:1280–7.PubMedCrossRef Liu CY, Liu YC, Wu C, et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;62:1280–7.PubMedCrossRef
39.
Zurück zum Zitat Ling LH, Kistler PM, Ellims AH, et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012;60:2402–8.PubMedCrossRef Ling LH, Kistler PM, Ellims AH, et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012;60:2402–8.PubMedCrossRef
40.
Zurück zum Zitat Piechnik SK, Ferreira VM, Lewandowski AJ, et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson. 2013;15:13.PubMedCentralPubMedCrossRef Piechnik SK, Ferreira VM, Lewandowski AJ, et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson. 2013;15:13.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Donekal S, Venkatesh BA, Liu YC, et al. Interstitial fibrosis, left ventricular remodeling and myocardial mechanical behavior in a population-based multi-ethnic cohort: MESA Study. Circ Cardiovasc Imaging. 2014. doi:10.1161/circimaging.113.001073.PubMed Donekal S, Venkatesh BA, Liu YC, et al. Interstitial fibrosis, left ventricular remodeling and myocardial mechanical behavior in a population-based multi-ethnic cohort: MESA Study. Circ Cardiovasc Imaging. 2014. doi:10.​1161/​circimaging.​113.​001073.PubMed
42.
Zurück zum Zitat Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98:1436–41.PubMedCrossRef Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98:1436–41.PubMedCrossRef
43.
Zurück zum Zitat Ellims AH, Iles LM, Ling LH, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012;14:76.PubMedCentralPubMedCrossRef Ellims AH, Iles LM, Ling LH, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012;14:76.PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging. 2012;5:726–33.PubMedCrossRef Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging. 2012;5:726–33.PubMedCrossRef
45.
Zurück zum Zitat Jellis C, Wright J, Kennedy D, et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging. 2011;4:693–702.PubMedCrossRef Jellis C, Wright J, Kennedy D, et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging. 2011;4:693–702.PubMedCrossRef
46.
Zurück zum Zitat Kellman P, Wilson JR, Xue H, et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012;14:64.PubMedCentralPubMedCrossRef Kellman P, Wilson JR, Xue H, et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012;14:64.PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Chan W, Duffy SJ, White DA, et al. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc sImaging. 2012;5:884–93.CrossRef Chan W, Duffy SJ, White DA, et al. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc sImaging. 2012;5:884–93.CrossRef
48.
Zurück zum Zitat Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488–97.PubMedCrossRef Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6:488–97.PubMedCrossRef
49.
Zurück zum Zitat Fontana M, Banypersad SM, Treibel TA, et al. Native t1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging. 2014;7:157–65.PubMedCrossRef Fontana M, Banypersad SM, Treibel TA, et al. Native t1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging. 2014;7:157–65.PubMedCrossRef
50.
Zurück zum Zitat Thompson RB, Chow K, Khan A, et al. T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging. 2013;6:637–45.PubMedCrossRef Thompson RB, Chow K, Khan A, et al. T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging. 2013;6:637–45.PubMedCrossRef
51.
Zurück zum Zitat Ling LH, Kalman JM, Ellims AH, et al. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhyth Electrophysiol. 2013;6:697–704.CrossRef Ling LH, Kalman JM, Ellims AH, et al. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhyth Electrophysiol. 2013;6:697–704.CrossRef
52.
Zurück zum Zitat Neilan TG, Mongeon FP, Shah RV, et al. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014;7:1–11.PubMedCrossRef Neilan TG, Mongeon FP, Shah RV, et al. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014;7:1–11.PubMedCrossRef
53.
Zurück zum Zitat Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6:1048–58.PubMedCrossRef Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6:1048–58.PubMedCrossRef
54.
Zurück zum Zitat Feng Y, He T, Carpenter JP, Jabbour A, et al. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging. 2013;3:588–93.CrossRef Feng Y, He T, Carpenter JP, Jabbour A, et al. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging. 2013;3:588–93.CrossRef
55.
Zurück zum Zitat Kozak MF, Redington A, Yoo SJ, et al. Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. Pediatr Radiol. 2014. doi:10.1007/s00247-013-2840-9.PubMed Kozak MF, Redington A, Yoo SJ, et al. Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. Pediatr Radiol. 2014. doi:10.​1007/​s00247-013-2840-9.PubMed
56.
Zurück zum Zitat Broberg CS, Chugh SS, Conklin C, et al. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727–34.PubMedCentralPubMedCrossRef Broberg CS, Chugh SS, Conklin C, et al. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727–34.PubMedCentralPubMedCrossRef
57.•
Zurück zum Zitat Wong TC, Piehler KM, Kang IA, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2014;35:657–64. The largest longitudinal study using T 1 mapping to date, describing differences between diabetic and nondiabetic individuals. Wong TC, Piehler KM, Kang IA, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2014;35:657–64. The largest longitudinal study using T 1 mapping to date, describing differences between diabetic and nondiabetic individuals.
58.
Zurück zum Zitat Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5:596–603.PubMedCentralPubMedCrossRef Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5:596–603.PubMedCentralPubMedCrossRef
59.
Zurück zum Zitat Lam CS, Roger VL, Rodeheffer RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53:1119–26.PubMedCentralPubMedCrossRef Lam CS, Roger VL, Rodeheffer RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53:1119–26.PubMedCentralPubMedCrossRef
60.•
Zurück zum Zitat Ellims AH, Shaw JA, Stub D, et al. Diffuse myocardial fibrosis evaluated by postcontrast t mapping correlates with left ventricular stiffness. J Am Coll Cardiol. 2014. doi:10.1016/j.jacc.2013.10.084. A carefully-performed study linking passive left ventricular stiffness with T 1 mapping. PubMed Ellims AH, Shaw JA, Stub D, et al. Diffuse myocardial fibrosis evaluated by postcontrast t mapping correlates with left ventricular stiffness. J Am Coll Cardiol. 2014. doi:10.​1016/​j.​jacc.​2013.​10.​084. A carefully-performed study linking passive left ventricular stiffness with T 1 mapping. PubMed
61.
Zurück zum Zitat Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126:1206–16.PubMedCentralPubMedCrossRef Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126:1206–16.PubMedCentralPubMedCrossRef
62.
63.
Zurück zum Zitat Beinart R, Khurram IM, Liu S, et al. Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm. 2013;10:1325–31.PubMedCrossRef Beinart R, Khurram IM, Liu S, et al. Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm. 2013;10:1325–31.PubMedCrossRef
64.
Zurück zum Zitat Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52:141–6.PubMedCrossRef Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52:141–6.PubMedCrossRef
65.
Zurück zum Zitat Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum. 1970;41:250–1.CrossRef Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum. 1970;41:250–1.CrossRef
66.
Zurück zum Zitat Bain AD. The choice of parameters in an NMR experiment. Application to the inversion-recovery T1 method. J Magn Reson. 1990;89:153–60. Bain AD. The choice of parameters in an NMR experiment. Application to the inversion-recovery T1 method. J Magn Reson. 1990;89:153–60.
67.
Zurück zum Zitat Zhang Y, Yeung HN, O'Donnell M, et al. Determination of sample time for T1 measurement. J Magn Reson Imaging. 1998;8:675–81.PubMedCrossRef Zhang Y, Yeung HN, O'Donnell M, et al. Determination of sample time for T1 measurement. J Magn Reson Imaging. 1998;8:675–81.PubMedCrossRef
68.
Zurück zum Zitat Ogg RJ, Kingsley PB. Optimized precision of inversion-recovery T1 measurements for constrained scan time. Magn Reson Med. 2004;51:625–30.PubMedCrossRef Ogg RJ, Kingsley PB. Optimized precision of inversion-recovery T1 measurements for constrained scan time. Magn Reson Med. 2004;51:625–30.PubMedCrossRef
69.
Zurück zum Zitat Kaptein R, Dijkstra K, Tarr C. A single-scan Fourier transform method for measuring spin-lattice relaxation times. J Magn Reson. 1976;24:295–300. Kaptein R, Dijkstra K, Tarr C. A single-scan Fourier transform method for measuring spin-lattice relaxation times. J Magn Reson. 1976;24:295–300.
70.
Zurück zum Zitat Deichmann R, Haase A. Quantification of T1 values by SNAPSHOT-FLASH NMR imaging. J Magn Reson. 1992;96:608–12. Deichmann R, Haase A. Quantification of T1 values by SNAPSHOT-FLASH NMR imaging. J Magn Reson. 1992;96:608–12.
71.
Zurück zum Zitat Stainsby JA, Slavin GS. Myocardial T1 mapping using SMART1Map: initial in vivo experience. J Cardiovasc Magn Reson. 2013;15 Suppl 1:13.CrossRef Stainsby JA, Slavin GS. Myocardial T1 mapping using SMART1Map: initial in vivo experience. J Cardiovasc Magn Reson. 2013;15 Suppl 1:13.CrossRef
72.
Zurück zum Zitat Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.PubMedCentralPubMedCrossRef Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.PubMedCentralPubMedCrossRef
73.
Zurück zum Zitat Chow K, Flewitt JA, Green JD, et al. Saturation recovery single-shot acquisition (SASHA) for myocardial T mapping. Magn Reson Med. 2013. doi:10.1002/mrm.24878. Chow K, Flewitt JA, Green JD, et al. Saturation recovery single-shot acquisition (SASHA) for myocardial T mapping. Magn Reson Med. 2013. doi:10.​1002/​mrm.​24878.
74.
Zurück zum Zitat Slavin GS, Stainsby JA. True T1 mapping with SMART1Map (saturation method using adaptive recovery times for cardiac T1 mapping): a comparison with MOLLI. J Cardiovasc Magn Reson. 2013;15 Suppl 1:3. Slavin GS, Stainsby JA. True T1 mapping with SMART1Map (saturation method using adaptive recovery times for cardiac T1 mapping): a comparison with MOLLI. J Cardiovasc Magn Reson. 2013;15 Suppl 1:3.
75.
Zurück zum Zitat Stainsby JA, Slavin GS. Comparing the accuracy and precision of SMART1Map, SASHA and MOLLI. J Cardiovasc Magn Reson. 2014;16 Suppl 1:11.CrossRef Stainsby JA, Slavin GS. Comparing the accuracy and precision of SMART1Map, SASHA and MOLLI. J Cardiovasc Magn Reson. 2014;16 Suppl 1:11.CrossRef
76.
Zurück zum Zitat Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.PubMedCentralPubMedCrossRef Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.PubMedCentralPubMedCrossRef
Metadaten
Titel
T1 Mapping in Heart Failure
verfasst von
Leah M. Iles
Glenn S. Slavin
Andrew J. Taylor
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 8/2014
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-014-9282-0

Weitere Artikel der Ausgabe 8/2014

Current Cardiovascular Imaging Reports 8/2014 Zur Ausgabe

Cardiac Computed Tomography (S Achenbach and T Villines, Section Editor)

High Risk Plaque Features on Coronary CT Angiography

Cardiac Computed Tomography (S Achenbach and T Villines, Section Editor)

Intra-Cycle Motion Correction in Coronary CT Angiography

Cardiac Computed Tomography (S Achenbach and T Villines, Section Editor)

Noncardiac Incidental Findings on Cardiac CT: A Step-by-Step Approach

Cardiac Computed Tomography (S Achenbach and T Villines, Section Editor)

Cardiac Masses on Cardiac CT: A Review

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.